Login / Signup

Convalescent plasma treatment of critically ill intensive care COVID-19 patients.

Monika LindemannVeronika LenzDietmar KnopHannes KlumpMira AltUlrich W AufderhorstLeonie SchipperSina SchwarzkopfLara MellerNina SteckelMichael KoldehoffAndreas HeinoldFalko M HeinemannJohannes FischerGabriele HutschenreuterCornelius KnabbeSebastian DolffThorsten BrennerUlf DittmerOliver WitzkeFrank HerbstreitPeter A HornAdalbert Krawczyk
Published in: Transfusion (2021)
Our data indicate that the efficacy of convalescent plasma treatment of critically ill COVID-19 patients who already had developed strong antiviral immune responses and organ complications is limited.
Keyphrases
  • sars cov
  • immune response
  • coronavirus disease
  • electronic health record
  • risk factors
  • dendritic cells
  • toll like receptor
  • inflammatory response
  • artificial intelligence